Hcy) est un acide aminé soufré formé au niveau intracellulaire à partir de la méthionine apportée par l'alimentation. L'Hcy n'est pas codée génétiquement et est absente des protéines ,
Prendre 12.5µL de chaque solution et ajouter 950 µL de H2O milliQ Sigma Aldrich BP 701, Applied Biosystems, vol.100, issue.38297 ,
Life Science Group, Hercules California 94547, USA 10 Eurobio. 91953 Les Ulis, France 11 UVP Dual Intensity Transilluminator 12 Gel Doc Scanner. BioRad, Life Science Group The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States, Clin Gastroenterol Hepatol, vol.5, pp.1424-1433, 2007. ,
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences, Gastroenterology, vol.126, issue.6, pp.1504-1521, 2004. ,
DOI : 10.1053/j.gastro.2004.01.063
Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999), Gut, vol.53, issue.6, pp.843-851, 1988. ,
DOI : 10.1136/gut.2003.025346
Circumstances of the diagnosis and clinical course of inflammatory bowel disease], Rev Prat, vol.55, pp.962-76, 2005. ,
Direct hospital costs for patients with inflammatory bowel disease in a Canadian Tertiary Care University Hospital, The American Journal of Gastroenterology, vol.17, issue.3, pp.677-83, 2000. ,
DOI : 10.1046/j.1365-2036.1996.107278000.x
Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital, Journal of Gastroenterology and Hepatology, vol.40, issue.2, pp.192-201, 2004. ,
DOI : 10.1136/gut.40.6.775
Unravelling the pathogenesis of inflammatory bowel disease, Nature, vol.124, issue.7152, pp.427-461, 2007. ,
DOI : 10.4049/jimmunol.176.2.705
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, Nature, vol.411, issue.6837, pp.599-603, 2001. ,
DOI : 10.1038/35079107
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease, Nature, vol.411, issue.6837, pp.603-609, 2001. ,
DOI : 10.1038/35079114
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene, Science, vol.314, issue.5804, pp.1461-1464, 2006. ,
DOI : 10.1126/science.1135245
Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan City, central China, Inflammatory Bowel Diseases, vol.26, issue.3, pp.212-219, 2006. ,
DOI : 10.1136/gut.26.2.158
Crohn's disease: the cold chain hypothesis, The Lancet, vol.362, issue.9400, pp.2012-2017, 2003. ,
DOI : 10.1016/S0140-6736(03)15024-6
Peyrin-Biroulet L. Helminths and inflammatory bowel diseases, Gastroenterol Clin Biol, 2008. ,
Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data, Inflammatory Bowel Diseases, vol.12, issue.3, pp.218-244, 2006. ,
DOI : 10.1053/gast.2003.50021
URL : https://hal.archives-ouvertes.fr/hal-00466309
Does the failure to acquire helminthic parasites predispose to Crohn???s disease?, The FASEB Journal, vol.14, issue.12, pp.1848-55, 2000. ,
DOI : 10.1017/S0031182000055347
The Genetics of Inflammatory Bowel Disease, Gastroenterology, vol.133, issue.4, pp.1327-1366, 2007. ,
DOI : 10.1053/j.gastro.2007.08.032
Dysbiosis as a prerequisite for IBD Darfeuille-Michaud A. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease, Gut J Clin Invest, vol.53117, issue.18, pp.10571566-74, 2004. ,
Bugging of the Intestinal Mucosa, New England Journal of Medicine, vol.357, issue.7, pp.708-718, 2007. ,
DOI : 10.1056/NEJMcibr073420
The Human Microbiome Project, Nature, vol.112, issue.7164, pp.804-814, 2007. ,
DOI : 10.1038/nature06244
New Concepts in the Pathophysiology of Inflammatory Bowel Disease, Annals of Internal Medicine, vol.143, issue.12, pp.895-904, 2005. ,
DOI : 10.7326/0003-4819-143-12-200512200-00007
Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?, Gut, vol.55, issue.3, pp.342-349, 2006. ,
DOI : 10.1136/gut.2005.065557
Reduced Paneth cell ??-defensins in ileal Crohn's disease, Proceedings of the National Academy of Sciences, vol.275, issue.51, pp.18129-18163, 2005. ,
DOI : 10.1074/jbc.M007816200
Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?, Gut, vol.56, issue.4, pp.577-83, 2007. ,
DOI : 10.1136/gut.2005.082925
[Epidemiology and natural history of chronic inflammatory bowel disease], Gastroenterol Clin Biol, vol.27, pp.76-80, 2003. ,
Crohn's disease over 20 years after diagnosis in a referral population, Gastroent??rologie Clinique et Biologique, vol.28, issue.12, pp.1233-1242, 2004. ,
DOI : 10.1016/S0399-8320(04)95216-5
Smoking cessation and the course of Crohn's disease: An intervention study, Gastroenterology, vol.120, issue.5, pp.1093-1102, 2001. ,
DOI : 10.1053/gast.2001.23231
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery, Gut, vol.54, issue.2, pp.237-278, 2005. ,
DOI : 10.1136/gut.2004.045294
Course of ulcerative colitis: Analysis of changes in disease activity over years, Gastroenterology, vol.107, issue.1, pp.3-11, 1994. ,
DOI : 10.1016/0016-5085(94)90054-X
Appendectomy protects against the development of ulcerative colitis but does not affect its course, The American Journal of Gastroenterology, vol.28, issue.11, pp.2834-2842, 2002. ,
DOI : 10.1111/j.1572-0241.2000.01680.x
Appendectomy and inflammatory bowel disease: the end of a dogma? Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis, 32. Odes HS, pp.491-21717, 2001. ,
L??sions ost??o-articulaires au cours des maladies inflammatoires chroniques de l???intestin, Gastroent??rologie Clinique et Biologique, vol.28, issue.5, pp.75-82, 2004. ,
DOI : 10.1016/S0399-8320(04)94991-3
Nutrition in inflammatory bowel disease, Current Opinion in Gastroenterology, vol.23, issue.4, pp.400-405, 2007. ,
DOI : 10.1097/MOG.0b013e3281ddb2a3
Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature, The American Journal of Medicine, vol.116, issue.7, pp.44-49, 2004. ,
DOI : 10.1016/j.amjmed.2003.12.011
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study, Thromb Haemost, vol.85, pp.430-434, 2001. ,
Epidemiology and Risk Factors for Colorectal Dysplasia and Cancer in Ulcerative Colitis, Gastroenterology Clinics of North America, vol.35, issue.3, pp.517-548, 2006. ,
DOI : 10.1016/j.gtc.2006.07.005
Review article: colorectal carcinoma and inflammatory bowel disease ,
The risk of cancer in patients with Crohn's disease, Aliment Pharmacol Ther Dis Colon Rectum, vol.2050, issue.39, pp.24-30839, 2004. ,
Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study, Gastroenterology, vol.133, issue.4, pp.1099-105, 2007. ,
DOI : 10.1053/j.gastro.2007.08.001
Cancer in inflammatory bowel disease, World Journal of Gastroenterology, vol.14, issue.3, pp.378-89, 2008. ,
DOI : 10.3748/wjg.14.378
Can regular use of 5-ASAs protect against the development of dysplasia and colorectal cancer in patients with ulcerative colitis?, Inflammatory Bowel Diseases, vol.100, issue.8, pp.1051-1053, 2007. ,
DOI : 10.1111/j.1572-0241.2005.50218.x
Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies, The American Journal of Gastroenterology, vol.18, issue.2, pp.1345-53, 2005. ,
DOI : 10.1097/00054725-200401000-00003
Aminosalicylate Therapy in the Prevention of Dysplasia and Colorectal Cancer in Ulcerative Colitis, Clinical Gastroenterology and Hepatology, vol.4, issue.11, pp.1346-50, 2006. ,
DOI : 10.1016/j.cgh.2006.08.014
Mortality by Medication Use Among Patients With Inflammatory Bowel Disease, 1996???2003, Gastroenterology, vol.133, issue.6, pp.1779-86, 1996. ,
DOI : 10.1053/j.gastro.2007.09.022
Long-term prognosis in Crohn's disease: an epidemiological study of patients diagnosed more than 20???years ago in Cardiff, Alimentary Pharmacology & Therapeutics, vol.21, issue.Suppl. 11, pp.59-65, 2007. ,
DOI : 10.1046/j.1532-5415.2002.50016.x
Meta-analysis: mortality in Crohn???s disease, Alimentary Pharmacology & Therapeutics, vol.21, issue.7, pp.861-70, 2007. ,
DOI : 10.1111/j.1365-2036.2006.03132.x
Efficacy and safety of tumor necrosis factor antagonists: meta-analysis of placebocontrolled trials Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2), Clin Gastroenterol Hepatol Gastroenterology, vol.49109, pp.129-164, 1995. ,
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis, New England Journal of Medicine, vol.353, issue.23, pp.2462-76, 2005. ,
DOI : 10.1056/NEJMoa050516
New drug classes for Crohn's disease: Beyond tumour necrosis factor antagonists Lancet, 2008. ,
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial, The Lancet, vol.371, issue.9613, pp.660-667, 2008. ,
DOI : 10.1016/S0140-6736(08)60304-9
Predictors of Crohn???s Disease, Gastroenterology, vol.130, issue.3, pp.650-656, 2006. ,
DOI : 10.1053/j.gastro.2005.12.019
IBD serological panels: Facts and perspectives, Inflammatory Bowel Diseases, vol.38, issue.12, pp.1561-1567, 2007. ,
DOI : 10.1136/gut.38.3.384
NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation, Trends in Microbiology, vol.14, issue.10, pp.432-440, 2006. ,
DOI : 10.1016/j.tim.2006.08.008
Invited review: NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease, Journal of Endotoxin Research, vol.2, issue.3, pp.135-144, 2007. ,
DOI : 10.1371/journal.pone.0000313
HOMOCYSTEINE METABOLISM, Annual Review of Nutrition, vol.19, issue.1, pp.217-263, 1999. ,
DOI : 10.1146/annurev.nutr.19.1.217
SULFUR AMINO ACID METABOLISM: Pathways for Production and Removal of Homocysteine and Cysteine, Annual Review of Nutrition, vol.24, issue.1, pp.539-77, 2004. ,
DOI : 10.1146/annurev.nutr.24.012003.132418
Homocysteine theory of arteriosclerosis, Atherosclerosis, vol.22, issue.2, pp.215-242, 1975. ,
DOI : 10.1016/0021-9150(75)90004-0
Total homocysteine in plasma or serum: methods and clinical applications, Clin Chem, vol.39, pp.1764-79, 1993. ,
Hyperhomocysteinemia and Low Pyridoxal Phosphate : Common and Independent Reversible Risk Factors for Coronary Artery Disease, Circulation, vol.92, issue.10, pp.2825-2855, 1995. ,
DOI : 10.1161/01.CIR.92.10.2825
Homocysteine and coronary atherosclerosis, Journal of the American College of Cardiology, vol.27, issue.3, pp.517-544, 1996. ,
DOI : 10.1016/0735-1097(95)00508-0
URL : https://doi.org/10.1016/0735-1097(95)00508-0
Homocysteinemia and vascular disease in end-stage renal disease, Kidney Int, vol.57, pp.11-18, 1996. ,
Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes, Kidney International, vol.52, issue.1, pp.10-20, 1997. ,
DOI : 10.1038/ki.1997.298
Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels, J Biol Chem, vol.272, pp.1935-1977, 1997. ,
Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis, FEBS Letters, vol.349, issue.120, pp.35-44, 2001. ,
DOI : 10.1016/S0140-6736(97)80014-1
Effect of homocysteinylation on human high-density lipoproteins: A correlation with paraoxonase activity, Metabolism, vol.52, issue.2, pp.146-51, 2003. ,
DOI : 10.1053/meta.2003.50033
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population, JAMA: The Journal of the American Medical Association, vol.270, issue.22, pp.2693-2701, 1993. ,
DOI : 10.1001/jama.1993.03510220049033
Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects, Clin Chem, vol.40, pp.873-81, 1994. ,
Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status, European Journal of Clinical Investigation, vol.81, issue.2, pp.79-87, 1992. ,
DOI : 10.1016/S0026-0495(98)90014-2
Dietary Determinants of Plasma Homocysteine Concentrations, Seminars in Vascular Medicine, vol.5, issue.02, pp.110-133, 2005. ,
DOI : 10.1055/s-2005-872397
Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy, J Lab Clin Med, vol.114, pp.473-501, 1989. ,
Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease, Pharmacological Reviews, vol.54, issue.4, pp.599-618, 2002. ,
DOI : 10.1124/pr.54.4.599
Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry, J Cardiovasc Risk, vol.5, pp.223-230, 1998. ,
Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification, Nature Genetics, vol.313, issue.2, pp.195-200, 1994. ,
DOI : 10.1056/NEJM199104253241701
Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR), Mammalian Genome, vol.9, issue.8, pp.652-658, 1998. ,
DOI : 10.1007/s003359900838
The human and mouse methylenetetrahydrofolate reductase (MTHFR) genes: genomic organization, mRNA structure and linkage to the CLCN6 gene, Gene, vol.257, issue.2, pp.279-89, 2000. ,
DOI : 10.1016/S0378-1119(00)00392-9
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nature Genetics, vol.11, issue.1, pp.111-114, 1995. ,
DOI : 10.1203/00006450-197711000-00004
Effect Of Metylenetetrahydrofolate Reductase 677 C-T, 1298 A-C, and 1317 T-C on Factor V 1691 Mutation in Turkish Deep Vein Thrombosis Patients, Thrombosis Research, vol.97, issue.3, pp.163-170, 2000. ,
DOI : 10.1016/S0049-3848(99)00157-7
Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular Disease : The Result of a Meta-Analysis, Circulation, vol.98, issue.23, pp.2520-2526, 1998. ,
DOI : 10.1161/01.CIR.98.23.2520
Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65, Circulation Am J Clin Nutr, vol.9373, issue.82, pp.7-91027, 1996. ,
Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) Biological cardiovascular risk factors and plasma homocysteine levels in the general Dutch population, Circulation Atherosclerosis, vol.99154, issue.84, pp.2383-8513, 1999. ,
Cloning, mapping and RNA analysis of the human methionine synthase gene, Human Molecular Genetics, vol.5, issue.12, pp.1851-1859, 1996. ,
DOI : 10.1093/hmg/5.12.1851
Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders, Human Molecular Genetics, vol.5, issue.12, pp.1867-74, 1996. ,
DOI : 10.1093/hmg/5.12.1867
Human Methionine Synthase, Journal of Biological Chemistry, vol.3, issue.6, pp.3628-3662, 1997. ,
DOI : 10.1073/pnas.76.1.405
Defects in human methionine synthase in cblG patients, Human Molecular Genetics, vol.5, issue.12, pp.1859-65, 1996. ,
DOI : 10.1093/hmg/5.12.1859
Maternal Genetic Effects, Exerted by Genes Involved in Homocysteine Remethylation, Influence the Risk of Spina Bifida, The American Journal of Human Genetics, vol.71, issue.5, pp.1222-1228, 2002. ,
DOI : 10.1086/344209
Methionine synthase (MTR) 2756 (A?????????G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome, American Journal of Medical Genetics Part A, vol.62, issue.3, pp.219-243, 2003. ,
DOI : 10.1086/301825
D919G polymorphism of methionine synthase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease, J Hum Genet J Cardiovasc Risk, vol.497, issue.92, pp.296-301197, 2000. ,
The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations, Atherosclerosis, vol.157, issue.2, pp.451-457, 2001. ,
DOI : 10.1016/S0021-9150(00)00739-5
Genetic Defects as Important Factors for Moderate Hyperhomocysteinemia, Clinical Chemistry and Laboratory Medicine, vol.11, issue.8, pp.698-704, 2001. ,
DOI : 10.1056/NEJM199707243370403
A Common Variant in Methionine Synthase Reductase Combined with Low Cobalamin (Vitamin B12) Increases Risk for Spina Bifida, Molecular Genetics and Metabolism, vol.67, issue.4, pp.317-340, 1999. ,
DOI : 10.1006/mgme.1999.2879
Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study, Atherosclerosis, vol.166, issue.1, pp.49-55, 2003. ,
DOI : 10.1016/S0021-9150(02)00204-6
Methylenetetrahydrofolate reductase (MTHFR) 677C>T and methionine synthase reductase (MTRR) 66A>G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid, Atherosclerosis, vol.168, issue.2, pp.315-337, 2003. ,
DOI : 10.1016/S0021-9150(03)00098-4
Neonatal Megaloblastic Anemia Due to Inherited Transcobalamin II Deficiency in Two Siblings, New England Journal of Medicine, vol.285, issue.21, pp.1163-70, 1971. ,
DOI : 10.1056/NEJM197111182852103
Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood, Blood, vol.97, issue.4, pp.1092-1100, 2001. ,
DOI : 10.1182/blood.V97.4.1092
Transcobalamin II 775G>C polymorphism and indices of vitamin B12 status in healthy older adults, Blood, vol.100, issue.2, pp.718-738, 2002. ,
DOI : 10.1182/blood-2002-01-0209
Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications, Reproductive Biology and Endocrinology, vol.2, issue.1, p.7, 2004. ,
DOI : 10.1186/1477-7827-2-7
Vascular and Cellular Stress in Inflammatory Bowel Disease: Revisiting the Role of Homocysteine, The American Journal of Gastroenterology, vol.19, issue.2, pp.1108-1123, 2007. ,
DOI : 10.1182/blood.V97.4.1092
Cystathionine ?? Synthase Deficiency Promotes Oxidative Stress, Fibrosis, and Steatosis in Mice Liver, Gastroenterology, vol.128, issue.5, pp.1405-1420, 2005. ,
DOI : 10.1053/j.gastro.2005.02.034
Homocysteine Triggers Mucosal Microvascular Activation in Inflammatory Bowel Disease, The American Journal of Gastroenterology, vol.112, issue.2, pp.886-95, 2005. ,
DOI : 10.1016/S0140-6736(98)05050-8
Homocysteine Antagonism of Nitric Oxide-Related Cytostasis in Salmonella typhimurium, Science, vol.272, issue.5260, pp.414-421, 1996. ,
DOI : 10.1126/science.272.5260.414
Homocysteine, the bad thiol, Hepatology, vol.1455, issue.5, pp.976-985, 2005. ,
DOI : 10.1016/S0925-4439(99)00049-6
Plasma total homocysteine in the active stage of ulcerative colitis, Journal of Gastroenterology and Hepatology, vol.8, issue.4, pp.739-782, 2006. ,
DOI : 10.3748/wjg.v8.i3.575
M??tabolisme des folates et canc??rogen??se colorectale, Gastroent??rologie Clinique et Biologique, vol.28, issue.6-7, pp.582-92, 2004. ,
DOI : 10.1016/S0399-8320(04)95015-4
Anomalies ??pig??n??tiques et carcinogen??se h??patique, Gastroent??rologie Clinique et Biologique, vol.30, issue.12, pp.1354-1363, 2006. ,
DOI : 10.1016/S0399-8320(06)73554-0
The oxidant stress of hyperhomocyst(e)inemia., Journal of Clinical Investigation, vol.98, issue.1, pp.5-7, 1996. ,
DOI : 10.1172/JCI118776
Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease., Journal of Clinical Investigation, vol.98, issue.1, pp.136-177, 1996. ,
DOI : 10.1172/JCI118757
Increased nitric oxide synthesis in ulcerative colitis, The Lancet, vol.341, issue.8843, pp.465-471, 1993. ,
DOI : 10.1016/0140-6736(93)90211-X
Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease, Clinical Biochemistry, vol.35, issue.7, pp.569-72, 2002. ,
DOI : 10.1016/S0009-9120(02)00361-2
Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells, Blood, vol.94, pp.959-67, 1999. ,
Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase, Journal of Biological Chemistry, vol.110, issue.27, pp.17012-17019, 1997. ,
DOI : 10.1172/JCI118771
Decreased Total and Corrected Antioxidant Capacity in Patients with Inflammatory Bowel Disease, Digestive Diseases and Sciences, vol.49, issue.9, pp.1433-1440, 2004. ,
DOI : 10.1023/B:DDAS.0000042242.22898.d9
Antioxidants as novel therapy in a murine model of colitis, The Journal of Nutritional Biochemistry, vol.16, issue.5, pp.297-304, 2005. ,
DOI : 10.1016/j.jnutbio.2004.09.007
NF-??B: pivotal mediator or innocent bystander in atherogenesis?, Journal of Clinical Investigation, vol.107, issue.3, pp.255-64, 2001. ,
DOI : 10.1172/JCI10373
Hyperhomocysteinemia Activates Nuclear Factor-??B in Endothelial Cells via Oxidative Stress, Circulation Research, vol.94, issue.1, pp.28-36, 2004. ,
DOI : 10.1161/01.RES.0000108264.67601.2C
Homocysteine Induces Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Aortic Endothelial Cells : Implications for Vascular Disease, Circulation, vol.103, issue.22, pp.2717-2740, 2001. ,
DOI : 10.1161/01.CIR.103.22.2717
Homocysteine accelerates endothelial cell senescence, FEBS Letters, vol.43, issue.1, pp.20-24, 2000. ,
DOI : 10.1159/000213885
Adhesion molecules in inflammatory bowel disease., Gut, vol.36, issue.5, pp.724-754, 1995. ,
DOI : 10.1136/gut.36.5.724
Modulation of tumor necrosis factor-??-mediated cytotoxicity by changes of the cellular methylation state: mechanism and in vivo relevance, International Immunology, vol.11, issue.4, pp.519-546, 1999. ,
DOI : 10.1016/S0092-8674(00)81377-X
Increased levels of C???reactive protein and interleukin???6 in hyperhomocysteinemic subjects, Scandinavian Journal of Clinical and Laboratory Investigation, vol.2, issue.1, pp.45-54, 2006. ,
DOI : 10.1097/00001721-200011020-00007
THE MAMMALIAN UNFOLDED PROTEIN RESPONSE, Annual Review of Biochemistry, vol.74, issue.1, pp.739-89, 2005. ,
DOI : 10.1146/annurev.biochem.73.011303.074134
Homocysteine Induces Programmed Cell Death in Human Vascular Endothelial Cells through Activation of the Unfolded Protein Response, Journal of Biological Chemistry, vol.193, issue.38, pp.35867-74, 2001. ,
DOI : 10.1111/j.1365-2362.1983.tb00121.x
Angiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis, Gastroenterology, vol.130, issue.7, pp.2060-73, 2006. ,
DOI : 10.1053/j.gastro.2006.03.054
Homocysteine Increases the Expression of Vascular Endothelial Growth Factor by a Mechanism Involving Endoplasmic Reticulum Stress and Transcription Factor ATF4, Journal of Biological Chemistry, vol.16, issue.15, pp.14844-52, 2004. ,
DOI : 10.1016/S0022-2836(02)00234-6
Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice, Gastroenterology, vol.124, issue.5, pp.1488-99, 2003. ,
DOI : 10.1016/S0016-5085(03)00276-2
Early detection: The power and the promise of DNA methylation markers, Nature Reviews Cancer, vol.3, issue.4, pp.253-66, 2003. ,
DOI : 10.1038/nrc1045
Hypomethylation of DNA from benign and malignant human colon neoplasms, Science, vol.228, issue.4696, pp.187-90, 1985. ,
DOI : 10.1126/science.2579435
DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis, Cancer, vol.35, issue.11, pp.2300-2306, 1996. ,
DOI : 10.1007/BF02253497
Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis, Gut, vol.54, issue.9, pp.1287-92, 2005. ,
DOI : 10.1136/gut.2004.062059
Does hyperhomocysteinaemia contribute to gastric carcinogenesis in Helicobacter pylori infected patients?, Gut, vol.561, issue.1480, 1480. ,
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies, Nature Reviews Microbiology, vol.115, issue.Suppl. 1, pp.820-852, 2004. ,
DOI : 10.1016/S0092-8674(03)00803-1
Communication in bacteria: an ecological and evolutionary perspective, Nature Reviews Microbiology, vol.184, issue.4, pp.249-58, 2006. ,
DOI : 10.4049/jimmunol.169.5.2636
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease, The American Journal of Gastroenterology, vol.3, issue.9, pp.2677-82, 2001. ,
DOI : 10.1111/j.1572-0241.2000.03193.x
Homocysteine, cysteine, and glutathione in human colonic mucosa: elevated levels of homocysteine in patients with inflammatory bowel disease, Digestive Diseases and Sciences, vol.48, issue.10, pp.2083-90, 2003. ,
DOI : 10.1023/A:1026338812708
High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?, Thromb Haemost, vol.80, pp.542-547, 1998. ,
Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease, European Journal of Gastroenterology & Hepatology, vol.17, issue.7, pp.739-783, 2005. ,
DOI : 10.1097/00042737-200507000-00008
[Factors associated with hyperhomocysteinemia in Crohn's disease], Gastroenterol Clin Biol, vol.25, pp.745-753, 2001. ,
Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study, The American Journal of Gastroenterology, vol.327, issue.7, pp.2143-2152, 2001. ,
DOI : 10.1073/pnas.93.26.15227
Hyperhomocysteinemia in greek patients with inflammatory bowel disease, Gastroenterology, vol.118, issue.4, pp.2347-51, 2000. ,
DOI : 10.1016/S0016-5085(00)83345-4
Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?, The American Journal of Gastroenterology, vol.17, issue.10, pp.2825-2855, 2000. ,
DOI : 10.1038/ng0595-111
Increased levels of homocysteine in patients with Crohn's disease are related to folate levels, The American Journal of Gastroenterology, vol.61, issue.12, pp.3498-502, 2000. ,
DOI : 10.1023/A:1018675624181
Crohn's disease and vitamin B12 metabolism, Digestive Diseases and Sciences, vol.29, issue.2, pp.1417-1439, 1996. ,
DOI : 10.1093/oxfordjournals.qjmed.a067265
Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease, Scand J Gastroenterol, vol.37, pp.62-69, 2002. ,
Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications, Gut, vol.45, issue.3, pp.389-94, 1999. ,
DOI : 10.1136/gut.45.3.389
Low vitamin B6 plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants, The American Journal of Gastroenterology, vol.131, issue.1, pp.112-119, 2003. ,
DOI : 10.1001/jama.279.5.359
Prothrombotic inherited abnormalities other than factor v leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease, The American Journal of Gastroenterology, vol.24, issue.5, pp.1448-54, 2001. ,
DOI : 10.1006/jsre.1996.0301
Inflammatory bowel disease are not associated with the major hereditary conditions predisposing to thrombosis, Gastroenterology, vol.114, pp.1465-1474, 2000. ,
DOI : 10.1016/S0016-5085(98)84505-8
Genotypes 677TT and 677CT+1298AC of methylenetetrahydrofolate reductase are associated with the severity of ulcerative colitis in central China, Gut, vol.54, issue.5, pp.733-737, 2005. ,
DOI : 10.1136/gut.2004.062539
High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease, European Journal of Gastroenterology & Hepatology, vol.15, issue.11, pp.1157-63, 2003. ,
DOI : 10.1097/00042737-200311000-00002
Sulfasalazine Inhibits the Absorption of Folates in Ulcerative Colitis, New England Journal of Medicine, vol.305, issue.25, pp.1513-1520, 1981. ,
DOI : 10.1056/NEJM198112173052506
Homocysteine and folate status in methotrexate???treated patients with rheumatoid arthritis, Rheumatology, vol.41, issue.6, pp.658-65, 2002. ,
DOI : 10.1016/S0889-857X(05)70358-6
The pharmacogenetics of methotrexate in inflammatory bowel disease, Pharmacogenetics and Genomics, vol.15, issue.10, pp.705-716, 2005. ,
DOI : 10.1097/01.fpc.0000172242.19675.33
Homocysteine and thrombosis: from basic science to clinical evidence, Thrombosis and Haemostasis, vol.94, pp.907-922, 2005. ,
DOI : 10.1160/TH05-05-0313
Pathogenesis of ulcerative colitis, Am J Pathol, vol.25, pp.657-79, 1949. ,
The Course and Prognosis of Ulcerative Colitis, Iii. Complications. Gut, vol.5, pp.1-22, 1964. ,
Increased carotid intima-media thickness in patients with inflammatory bowel disease, Alimentary Pharmacology and Therapeutics, vol.22, issue.9, pp.839-885, 2005. ,
DOI : 10.1111/j.1365-2036.2005.02657.x
Inflammatory Bowel Disease Promotes Venous Thrombosis Earlier in Life, Scandinavian Journal of Gastroenterology, vol.82, issue.170, pp.619-642, 2000. ,
DOI : 10.1016/0049-3848(96)00060-6
A Common Mutation in the Methylenetetrahydrofolate Reductase Gene (C677T) Increases the Risk for Deep-Vein Thrombosis in Patients With Mutant Factor V (Factor V:Q506), Arteriosclerosis, Thrombosis, and Vascular Biology, vol.17, issue.9, pp.1662-1668, 1997. ,
DOI : 10.1161/01.ATV.17.9.1662
Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens., The American Journal of Gastroenterology, vol.130, issue.12, 2006. ,
DOI : 10.1053/gast.2000.18159
Terminal Ileum Resection Is Associated With Higher Plasma Homocysteine Levels in Crohn's Disease, Journal of Clinical Gastroenterology, vol.33, issue.2, pp.132-138, 2001. ,
DOI : 10.1097/00004836-200108000-00008
Genetic Variation in the MTHFR Gene Influences Thiopurine Methyltransferase Activity, Clinical Chemistry, vol.51, issue.12, pp.2371-2375, 2005. ,
DOI : 10.1373/clinchem.2005.053157
Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide, British Journal of Pharmacology, vol.70, issue.2, pp.269-74, 1997. ,
DOI : 10.1042/bj3140021
Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population, Atherosclerosis, vol.146, issue.1, pp.133-173, 1999. ,
DOI : 10.1016/S0021-9150(99)00111-2
Elevated plasma homocysteine elicits an increase in antioxidant enzyme activity, Free Radical Research, vol.73, issue.2, pp.171-180, 2000. ,
DOI : 10.1016/0049-3848(80)90175-9
Oxidative DNA Damage and Antioxidant Activity in Patients with Inflammatory Bowel Disease, Digestive Diseases and Sciences, vol.82, issue.5, pp.1636-1677, 2007. ,
DOI : 10.1016/0016-5085(91)90729-5
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, vol.55, issue.6, pp.749-53, 2006. ,
DOI : 10.1136/gut.2005.082909
Is ileocaecal Crohn's disease L1 or L3 according to the Montreal classification?, Gut, vol.57, issue.3, p.427, 2008. ,
DOI : 10.1136/gut.2007.140939
Association of MTRR 66A>G Polymorphism With Superoxide Dismutase and Disease Activity in Patients With Crohn's Disease, The American Journal of Gastroenterology, vol.107, issue.2, pp.399-406, 2008. ,
DOI : 10.1084/jem.194.9.1207
Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China, BMC Medical Genetics, vol.102, issue.Suppl ,
DOI : 10.1111/j.1572-0241.2006.00943.x
Folate Deficiency and Plasma Homocysteine during Increased Oxidative Stress, New England Journal of Medicine, vol.357, issue.4, pp.421-423, 2007. ,
DOI : 10.1056/NEJMc066569
Clinical outcome of Crohn??s disease according to the Vienna classification: disease location is a useful predictor of disease course, European Journal of Gastroenterology & Hepatology, vol.18, issue.3, pp.255-61, 2006. ,
DOI : 10.1097/00042737-200603000-00005
Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults, The American Journal of Clinical Nutrition, vol.5, issue.4, pp.835-876, 2006. ,
DOI : 10.1093/jn/130.2.129
Mutations in Clotting Factors and Inflammatory Bowel Disease, The American Journal of Gastroenterology, vol.55, issue.2, pp.338-381, 2007. ,
DOI : 10.1016/S0002-9270(98)00051-3
Regulation of Murine Intestinal Inflammation by Reactive Metabolites of Oxygen and Nitrogen, The Journal of Experimental Medicine, vol.87, issue.9, pp.1207-1225, 2001. ,
DOI : 10.1046/j.1365-2249.2000.01090.x
Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations, The American Journal of Clinical Nutrition, vol.26, issue.suppl, pp.701-708, 2006. ,
DOI : 10.1073/pnas.261469998
Hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C???T and 1298A???C mutations in patients with inflammatory bowel disease, Revista Espa??ola de Enfermedades Digestivas, vol.97, issue.7, pp.497-504, 2005. ,
DOI : 10.4321/S1130-01082005000700005
Mitochondrial Dysfunction in Atherosclerosis, Circulation Research, vol.100, issue.4, pp.460-73, 2007. ,
DOI : 10.1161/01.RES.0000258450.44413.96
Association of MTRRA66G polymorphism (but not of MTHFR C677T and A1298C, MTRA2756G, TCN C776G) with homocysteine and coronary artery disease in the French population, Thromb Haemost, vol.94, pp.510-515, 2005. ,
NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population, Alimentary Pharmacology and Therapeutics, vol.117, issue.12, pp.1465-70, 2003. ,
DOI : 10.1016/S0016-5085(99)70390-2
NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality, World Journal of Gastroenterology, vol.10, issue.7, pp.1069-71, 2004. ,
DOI : 10.1136/gut.42.4.477
Upregulation of transcobalamin (TC) and its receptor in colonic inflammation: Effect of homocysteine ,
B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke, Clinical Science, vol.107, issue.5, pp.477-84, 2004. ,
DOI : 10.1042/CS20040134
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction, New England Journal of Medicine, vol.354, issue.15, pp.1578-88, 2006. ,
DOI : 10.1056/NEJMoa055227
Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease, Inflammatory Bowel Diseases, vol.297, issue.2, pp.242-250, 2008. ,
DOI : 10.1001/jama.297.21.2351
Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn???s disease, Alimentary Pharmacology & Therapeutics, vol.4, issue.7, pp.797-804, 2007. ,
DOI : 10.1136/gut.40.2.228